Infectious Diseases News and Research

RSS

Our Planet, Our Health; Importance of Understanding Planetary Health

For world health day, we speak to Dr. Sam Myers, director of the Planetary Health Alliance, about the importance of raising awareness surrounding planetary health.

7 Apr 2022

Israeli research confirms BNT162b2 booster's effectiveness

Researchers explore the use of a third dose of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

6 Apr 2022

Insufficient sleep could play a role in the development of type 2 diabetes

People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found.

6 Apr 2022

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them.

6 Apr 2022

Developing and manufacturing custom recombinant antibodies for R&D

In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.

From Sino Biological Inc. 6 Apr 2022

New study finds community acquired drug-resistant UTIs to be more deadly

A new study led by Australia’s national science agency, CSIRO, has found the spread of drug-resistant bacteria in the community is increasing the risk of death for common infections such as urinary tract infections (UTIs), which affect around one in two women and one in 20 men in their lifetime.

6 Apr 2022

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Researchers evaluate the effectiveness of four COVID-19 vaccines against symptomatic infection, hospitalization, and death in convalescent individuals.

5 Apr 2022

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

Critical Path Institute's Type 1 Diabetes Consortium (T1DC) today announced that the European Medicines Agency has issued a positive qualification opinion for pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes (T1D) prevention trials.

5 Apr 2022

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

The SAVE initiative assesses the impact of SARS-CoV-2 variants on diagnostics, vaccines, and therapies, as well as communicating public health dangers.

4 Apr 2022

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

Researchers compare the neutralization of BA.1 and BA.2 strains in immunized people who had received two doses and a booster BNT162b2 mRNA vaccine.

4 Apr 2022

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

A new Swedish study examines the protective effect of immunity engendered by natural infection in contrast to hybrid immunity.

4 Apr 2022

Global study demonstrates some benefits of flu vaccine in people with heart failure

People with heart failure who received an annual flu shot had lower rates of pneumonia and hospitalization on a year-round basis and a reduction in major cardiovascular events during peak flu season, in a study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

Scientists at Northwestern Medicine are using new advances in CRISPR gene-editing technology to uncover new biology that could lead to longer-lasting treatments and new therapeutic strategies for Human Immunodeficiency Virus (HIV).

1 Apr 2022

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

In a paper in the journal Nature, Los Alamos National Laboratory scientists Bette Korber, Hyejin Yoon, Will Fischer and James Theiler, among nearly 130 authors from institutions around the world, describe their groundbreaking collaborative work, "Defining the risk of SARS-CoV-2 variants on immune protection."

1 Apr 2022

Research illuminates why immune disorders affect only one of two identical twins

Scientists have long queried the causes of immune disorders in only one of two identical twins with identical genes. New research from the Wellcome Sanger Institute, the Josep Carreras Leukaemia Research Institute in Spain and their collaborators, has found the answer lies in both alterations in immune cell-cell communication and the epigenome, the host of biological processes that regulate how our genes function.

1 Apr 2022

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Connie Houtz didn't think covid would be that bad. She'd seen many people in this rural hamlet in central Pennsylvania get infected yet recover within a few days. She did not get vaccinated because she worried about how a new vaccine, developed in record time, might affect her heart condition.

1 Apr 2022

Managing hazardous waste during the Covid-19 pandemic

In a hospital or medical environment, preventing and delaying the spread of Coronavirus goes far beyond washing hands. Good biosecurity is essential, and the safe disposal of infected waste will save lives.

From Inciner8 Limited 1 Apr 2022

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Faculty from the Departments of Microbiology, Medicine Genetics and Genomic Sciences, and Pathology and Molecular Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai play key roles in a National Institutes of Health (NIH) program set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program, called SARS-CoV-2 Assessment of Viral Evolution (SAVE) and described in a paper published March 31 in Nature, assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

31 Mar 2022

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

Early treatment of newly diagnosed COVID-19 patients with plasma extracted from individuals who have recovered from the disease reduces the need for hospitalization by more than 50%, according to a new nationwide clinical trial.

31 Mar 2022

UIC researchers projected to receive $22 million to study long COVID-19

A team of University of Illinois Chicago researchers is projected to receive approximately $22 million from the National Institutes of Health over four years to research long COVID-19.

31 Mar 2022

Infectious Diseases News and Research

Our Planet, Our Health; Importance of Understanding Planetary Health

Israeli research confirms BNT162b2 booster's effectiveness

Insufficient sleep could play a role in the development of type 2 diabetes

Study captures the immune effect of COVID-19 vaccine in patients with multiple myeloma

Developing and manufacturing custom recombinant antibodies for R&D

New study finds community acquired drug-resistant UTIs to be more deadly

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

EMA issues qualification opinion for islet autoantibodies as enrichment biomarkers for T1D prevention trials

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

Global study demonstrates some benefits of flu vaccine in people with heart failure

Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Research illuminates why immune disorders affect only one of two identical twins

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

Managing hazardous waste during the Covid-19 pandemic

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

Convalescent plasma treatment for newly diagnosed COVID-19 patients may reduce hospitalization risk

UIC researchers projected to receive $22 million to study long COVID-19

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News